|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/192 | (2006.01) |
| A61K 45/06 | (2013.01) | ||
| A61K 31/485 | (2006.01) | ||
| A61K 31/485 | (2013.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61K 9/2054 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 17/04 | (2018.01) | ||
| A61P 17/04 | (2006.01) |
| (11) | Number of the document | 3432871 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17770981.3 |
| Date of filing the European patent application | 2017-03-21 | |
| (97) | Date of publication of the European application | 2019-01-30 |
| (45) | Date of publication and mention of the grant of the patent | 2023-11-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/023398 |
| Date | 2017-03-21 |
| (87) | Number | WO 2017/165409 |
| Date | 2017-09-28 |
| (30) | Number | Date | Country code |
| 201662311134 P | 2016-03-21 | US | |
| 201662412584 P | 2016-10-25 | US |
| (72) |
SCIASCIA, Thomas , US
GOOD, Jennifer , US
HAWI, Amale , US
|
| (73) |
Trevi Therapeutics, Inc. ,
195 Church Street
14th Floor, New Haven, Connecticut 06510,
US
|
| (54) | TREATMENT OF UREMIC PRURITUS |
| TREATMENT OF UREMIC PRURITUS |